1,3 disubstituted pyrrolidines as alpha -2- adrenoceptor antagonists
申请人:——
公开号:US20030008874A1
公开(公告)日:2003-01-09
The invention provides compounds of formula (I) wherein R
0
, R
1
, R
2
and A are as defined in the description, and the preparation thereof. The compounds of formula (I) have high affinity as &agr;
2
adrenoceptors and hence are useful as pharmaceuticals.
1,3 disubstituted pyrrolidines as α-2-adrenoceptor antagonists
申请人:Novartis AG
公开号:US07012085B2
公开(公告)日:2006-03-14
The invention provides compounds of formula (I) wherein R0, R1, R2 and A are as defined in the description, and the preparation thereof. The compounds of formula (I) have high affinity as α2 adrenoceptors and hence are useful as pharmaceuticals.
1,3-DISUBSTITUTED PYRROLIDINES AS ALPHA-2-ADRENOCEPTOR ANTAGONISTS
申请人:Novartis AG
公开号:EP1257547A1
公开(公告)日:2002-11-20
US7012085B2
申请人:——
公开号:US7012085B2
公开(公告)日:2006-03-14
[EN] 1,3-DISUBSTITUTED PYRROLIDINES AS ALPHA-2-ADRENOCEPTOR ANTAGONISTS<br/>[FR] PYRROLIDINES 1,3-DISUBSTITUEES EN TANT QU'ANTAGONISTES DU RECEPTEUR ADRENERGIQUE ALPHA 2
申请人:NOVARTIS AG
公开号:WO2001055132A1
公开(公告)日:2001-08-02
The invention provides compounds of formula (I) wherein R0, R1, R2 and A are as defined in the description, and the preparation thereof. The compounds of formula (I) have high affinity as α2 adrenoceptors and hence are useful as pharmaceuticals.